Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation

Scope & Guideline

Exploring innovative solutions for pulmonary challenges.

Introduction

Welcome to your portal for understanding Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2372-952x
PublisherCOPD FOUNDATION
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2018 to 2024
AbbreviationCOPD-J COPD FDN / Chronic Obstr. Pulm. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCOPD FOUNDATION, DENVER, CO 00000

Aims and Scopes

The journal 'Chronic Obstructive Pulmonary Diseases - Journal of the COPD Foundation' primarily focuses on advancing knowledge and understanding of chronic obstructive pulmonary disease (COPD) through diverse research methodologies, including clinical studies, epidemiological analyses, and innovative treatment approaches. It aims to address various aspects of COPD, from pathophysiology to patient management and health disparities.
  1. Clinical Management of COPD:
    The journal emphasizes research on clinical practices related to the diagnosis, treatment, and management of COPD, including pharmacological interventions, rehabilitation strategies, and the impact of comorbidities.
  2. Epidemiological Studies:
    There is a strong focus on understanding the prevalence, risk factors, and health outcomes associated with COPD, often through large-scale population studies and registries.
  3. Patient-Centered Research:
    Research that highlights patient experiences, quality of life, and self-management strategies for COPD patients is a core area. This includes qualitative studies that explore the psychosocial aspects of living with the disease.
  4. Innovative Therapeutics and Interventions:
    The journal publishes studies on novel treatments and interventions, such as biologics, telemedicine, and dietary impacts, aimed at improving COPD management and patient outcomes.
  5. Health Disparities and Access to Care:
    Research addressing disparities in COPD care among different populations, including socioeconomic and racial/ethnic inequalities, is a significant focus area.
  6. Pathophysiology and Biomarkers:
    Investigations into the underlying mechanisms of COPD, including genetic factors, inflammation, and the role of biomarkers in disease progression, are regularly featured.
The journal has identified several emerging themes that reflect current trends in COPD research, showcasing a shift towards more integrative, patient-centered, and innovative approaches in understanding and managing the disease.
  1. Impact of Lifestyle Factors:
    Recent publications increasingly explore the effects of lifestyle factors, including diet, physical activity, and smoking cessation, on COPD outcomes, highlighting the importance of holistic management.
  2. Quality of Life and Patient Experience:
    There is a notable trend towards emphasizing the quality of life and patient experiences in COPD management, with studies focusing on psychosocial aspects, self-management, and patient-reported outcomes.
  3. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote monitoring tools for COPD management has gained significant attention, particularly in the context of the COVID-19 pandemic, reflecting a shift towards innovative care delivery models.
  4. Health Disparities Research:
    The journal has seen a rise in studies addressing health disparities in COPD, focusing on the experiences of underrepresented populations and the impact of sociodemographic factors on care outcomes.
  5. Microbiome and Gut-Lung Interactions:
    Emerging research on the role of the microbiome and gut-lung interactions in COPD pathogenesis has gained traction, indicating a growing interest in understanding the disease through a broader biological lens.

Declining or Waning

While the journal maintains a comprehensive focus on COPD, certain themes have shown a decline in prominence over recent years, reflecting shifts in research priorities and emerging areas of interest.
  1. Traditional Pharmacological Approaches:
    There appears to be a waning focus on traditional pharmacological treatments for COPD, such as long-acting bronchodilators and inhaled corticosteroids, as newer therapeutic modalities and personalized medicine approaches gain traction.
  2. Basic Science Research:
    The journal has seen a reduction in the publication of basic science studies that do not directly translate to clinical applications, as there is a stronger emphasis on translational research and patient-centered studies.
  3. Longitudinal Cohort Studies:
    While still relevant, the frequency of longitudinal cohort studies focusing solely on COPD progression without integrating patient-reported outcomes or quality of life metrics seems to be decreasing.
  4. General COPD Awareness Campaigns:
    Research focused on general awareness and educational campaigns regarding COPD has diminished, possibly due to a shift towards more targeted interventions and specific patient populations.

Similar Journals

International Journal of Chronic Obstructive Pulmonary Disease

Advancing Knowledge in COPD Management
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-2005Frequency: 1 issue/year

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Chronic Respiratory Disease

Advancing research for healthier lungs.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-9723Frequency: 1 issue/year

Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.

Thoracic Research and Practice

Connecting Global Minds for Thoracic Excellence
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Tuberkuloz ve Toraks-Tuberculosis and Thorax

Championing excellence in thoracic disease scholarship.
Publisher: TURKISH ASSOC TUBERCULOSIS & THORAXISSN: 0494-1373Frequency: 4 issues/year

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Shaping the future of respiratory and critical care medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

Annals of the American Thoracic Society

Exploring new frontiers in pulmonary health and clinical excellence.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Jornal Brasileiro de Pneumologia

Transforming respiratory medicine with groundbreaking discoveries.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Unveiling breakthroughs in respiratory and critical care.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

RESPIRATORY RESEARCH

Leading the Charge in Respiratory Health Advancements
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

Expert Review of Respiratory Medicine

Exploring the Frontiers of Pulmonary Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.